GSK will apply to the FDA in the 2nd half of 2006 for approval of Tykerb (Lapatinib) It has already been fast tracked by the FDA so we are anticipating a swift approval.
We will be meeting with GSK in Atlanta next week and we will certainly discuss upcoming clinical trials as well as compassionate use of Tykerb prior to approval.
Warmest Regards
Joe
|